| Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM (NCT01525225) | AstraZeneca | 2012-09-01 |
| Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis (NCT01728701) | Sanaria Inc. | 2012-09-01 |
| Phase 1b Safety and Efficacy Study of TRU-016 (NCT01644253) | Aptevo Therapeutics | 2012-09-01 |
| Intensive Outpatient Services for Teens (NCT01732601) | Brown University | 2012-09-01 |
| Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ART (NCT01627678) | Bionor Immuno AS | 2012-09-01 |
| A Study of LY2940680 in Healthy Participants (NCT01681186) | Eli Lilly and Company | 2012-09-01 |
| Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults (NCT01739231) | PATH | 2012-09-01 |
| Darbe Administration in Newborns Undergoing Cooling for Encephalopathy (NCT01471015) | University of Utah | 2012-09-01 |
| A Bioequivalence Study of an Oral Solution of Copegus (Ribavirin) Compared to Copegus Tablets (NCT01697436) | Hoffmann-La Roche | 2012-09-01 |
| Comparative Pharmacokinetics and Safety of TNX-102 SL Tablets and Cyclobenzaprine Oral Tablet in Healthy Adults (NCT01689259) | Tonix Pharmaceuticals, Inc. | 2012-09-01 |
| A Phase I Study: PET Imaging of Cancer Patients Using [18F] 4-L-Fluoroglutamine (2S,4R) (NCT01697930) | Memorial Sloan Kettering Cancer Center | 2012-09-01 |
| A Bioequivalence Study Comparing A Fixed Dose Combination Formulation, Rin 150 And Individual Reference Drugs In Healthy Volunteers (NCT02014272) | Pfizer | 2012-09-01 |
| Evaluation of the Depth and Duration of Anesthesia From Heated Lidocaine/Tetracaine (Synera®) Patches Compared With 5% Lidocaine (Lidoderm®) Patches Applied to Healthy Adult Volunteers (NCT01688518) | CRI Lifetree | 2012-09-01 |
| Injection of Local Anesthetic to Trocar Insertion Sites After Laparoscopy (NCT01688596) | Milton S. Hershey Medical Center | 2012-09-01 |
| Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer (NCT01693276) | Olugbenga Olowokure | 2012-09-01 |
| Safety Study of an Oral Vaccine to Prevent Seasonal Influenza (NCT01688297) | Vaxart | 2012-09-01 |
| Effectiveness of OZ439 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Volunteers (NCT02453581) | Medicines for Malaria Venture | 2012-09-01 |
| Study in Healthy Male Subjects to Demonstrate Bioequivalence of 1600 μg Selexipag Administered as Eight Tablets of 200 μg or as Single Tablet of 1600 μg (NCT02206295) | Actelion | 2012-09-01 |
| A Study of Intratumoral Injection of Interleukin-2 and Ipilimumab in Patients With Unresectable Stages III-IV Melanoma (NCT01672450) | University of Utah | 2012-09-01 |
| T Cell Effector and Regulatory Mechanisms in Asthma (NCT01612936) | Andrew D. Luster, M.D.,Ph.D. | 2012-09-01 |
| Study Evaluating the Safety and Intraocular Pressure (IOP) Lowering Response of Brimonidine Tartrate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular Hypertension (NCT01687426) | Eye Therapies, LLC | 2012-09-01 |
| SHP-141C in Plaque Type Psoriasis (NCT01646567) | TetraLogic Pharmaceuticals | 2012-09-01 |
| Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm (NCT01525706) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2012-09-01 |
| The Effect of Oral Administration of 9-cis β Carotene Rich Powder of the Alga Dunaliella Bardawil (NCT01680510) | Sheba Medical Center | 2012-09-01 |
| Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery (NCT01705340) | National Cancer Institute (NCI) | 2012-09-01 |
| Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma (NCT01665183) | Polaris Group | 2012-09-01 |
| Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors (NCT01762410) | Piramal Enterprises Limited | 2012-09-01 |
| Depression Outcomes Study of Exercise (NCT00964054) | National Institute of Mental Health (NIMH) | 2012-09-01 |
| A Study of Single Dose RO6811135 in Healthy Volunteers (NCT01676584) | Hoffmann-La Roche | 2012-09-01 |
| ARMS - Rapidly Generated Multivirus-Specific CTLs for Prophylaxis & Treatment of EBV, CMV, Adenovirus, HHV6 & BK Virus (NCT01570283) | AlloVir | 2012-09-01 |
| Safety Tolerability & Pharmacokinetics of Co-administered Single Doses of OZ439 & Piperaquine to Healthy Subjects (NCT01660022) | Medicines for Malaria Venture | 2012-09-01 |
| A STUDY TO EVALUATE THE EFFICACY OF CJH1 (CLR4001) IN PARKINSON'S DISEASE (NCT01684475) | Alexandra Marine and General Hospital | 2012-09-01 |
| A PhaseI/IIa Study to Determine the Safety and Tolerability of MA09-hRPE Cells in Patients With Advanced Dry AMD (NCT01674829) | CHABiotech CO., Ltd | 2012-09-01 |
| Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation (NCT01685996) | Johns Hopkins University | 2012-09-01 |
| Saudi Outcomes of ECMO-treated MERS-CoV Patients (NCT02627378) | Imam Abdulrahman Bin Faisal University | 2012-09-01 |
| Pharmacokinetic and Safety Study of Daclatasvir in Patients With Renal Impairment (NCT01830205) | Bristol-Myers Squibb | 2012-09-01 |
| Multiple-Dose Study of Effect of Bardoxolone Methyl on QT/QTC Interval Volunteers (NCT01689116) | Biogen | 2012-08-31 |
| A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Non-typeable Haemophilus Influenzae (NTHi) Investigational Vaccine (GSK2838497A) in Current and Former Smokers (NCT01678677) | GlaxoSmithKline | 2012-08-31 |
| Alisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or B-cell Low Grade Non-Hodgkin Lymphoma (NCT01695941) | National Cancer Institute (NCI) | 2012-08-31 |
| A Study of Ponatinib in Japanese Participants With Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL) (NCT01667133) | Ariad Pharmaceuticals | 2012-08-31 |
| Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies (NCT01705106) | University of Chicago | 2012-08-29 |
| Tissue Engineered Nasal Cartilage for Regeneration of Articular Cartilage (NCT01605201) | University Hospital, Basel, Switzerland | 2012-08-29 |
| A Phase 1, Dose Escalation Study to Assess the Safety and Tolerability of ASP9853 With Either Docetaxel or Paclitaxel in Patients With Advanced Non-hematologic Malignancies (NCT01705483) | Astellas Pharma Global Development, Inc. | 2012-08-28 |
| A Study of MEK162 and AMG 479 in Patients With Selected Solid Tumors (NCT01562899) | Pfizer | 2012-08-27 |
| Bioequivalence - Duodart Against Avodart & Omnic (NCT01657851) | GlaxoSmithKline | 2012-08-23 |
| Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age (NCT01659086) | GlaxoSmithKline | 2012-08-22 |
| Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer (NCT01624441) | National Cancer Institute (NCI) | 2012-08-21 |
| Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naive Participants With Castration-Resistant Prostate Cancer (NCT01666314) | Millennium Pharmaceuticals, Inc. | 2012-08-20 |
| A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas (NCT01625351) | St. Jude Children's Research Hospital | 2012-08-20 |
| Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer (NCT01536054) | Roswell Park Cancer Institute | 2012-08-20 |
| Study to Evaluate the Safety and Tolerability of Tirabrutinib (ONO/GS-4059) Given as Monotherapy in Participants With Relapsed/Refractory NHL and CLL (NCT01659255) | Gilead Sciences | 2012-08-17 |
| Study to Evaluate the Pharmacokinetics, Safety and Tolerability of GSK557296 in Healthy Women Volunteers After Single and Repeat Dosing (NCT01669083) | GlaxoSmithKline | 2012-08-16 |
| A Four-way Crossover, Single and Repeat Dose Study to Determine the Dose Proportionality and Absolute Bioavailability of Fluticasone Furoate Inhalation Powder Administered by Novel Dry Powder Inhaler (NDPI) (NCT01669070) | GlaxoSmithKline | 2012-08-15 |
| QUILT-3.020: A Study of ALT-801 in Patients With Relapsed or Refractory Multiple Myeloma (NCT01670994) | Altor BioScience | 2012-08-14 |
| A Study of the Pharmacokinetics and Safety of SM03 in Patients With Rheumatoid Arthritis (NCT04704492) | SinoMab BioScience Ltd | 2012-08-14 |
| A Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic Melanoma (NCT01656642) | Genentech, Inc. | 2012-08-13 |
| Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT01665794) | University of Chicago | 2012-08-13 |
| A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C -GSK1322322 After an Intravenous and an Oral Dose (NCT01663389) | GlaxoSmithKline | 2012-08-10 |
| Study of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome (NCT01433965) | University of California, Davis | 2012-08-08 |
| Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML) (NCT01460498) | M.D. Anderson Cancer Center | 2012-08-08 |
| Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Non-typeable Haemophilus Influenzae (NTHI) Vaccine (NCT01657526) | GlaxoSmithKline | 2012-08-08 |
| A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal Adenocarcinoma (NCT01634685) | University of Texas Southwestern Medical Center | 2012-08-08 |
| Humanized 3F8 Monoclonal Antibody (Hu3F8) When Combined With Interleukin-2 in Patients With High-Risk Neuroblastoma and GD2-positive Solid Tumors (NCT01662804) | Memorial Sloan Kettering Cancer Center | 2012-08-06 |
| Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine and Losartan in Health Volunteers (NCT01648231) | GlaxoSmithKline | 2012-08-06 |
| Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction (NCT01638533) | National Cancer Institute (NCI) | 2012-08-03 |
| Viral Therapy in Treating Patient With Refractory Liver Cancer or Advanced Solid Tumors (NCT01628640) | Mayo Clinic | 2012-08-03 |
| Edible Plant Exosome Ability to Prevent Oral Mucositis Associated With Chemoradiation Treatment of Head and Neck Cancer (NCT01668849) | University of Louisville | 2012-08-02 |
| An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma (NCT01592370) | Bristol-Myers Squibb | 2012-08-02 |
| Treatment of Residual Amblyopia With Donepezil (NCT01584076) | Boston Children's Hospital | 2012-08-01 |
| A Trial to Explore Symptomatic Therapy for Application Site Reaction to SPM962 in Healthy Subject (NCT01737931) | Otsuka Pharmaceutical Co., Ltd. | 2012-08-01 |
| Exercise and Low-Dose Rapamycin in Older Adults With CAD:Cardiac Rehabilitation And Rapamycin in Elderly (CARE) Trial (NCT01649960) | Mayo Clinic | 2012-08-01 |
| Combined Infusion of Cytotoxic T-Lymphocytes and Vaccination (NCT02843321) | University of Sydney | 2012-08-01 |
| Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Atorvastatin (NCT01635946) | Astellas Pharma Global Development, Inc. | 2012-08-01 |
| Safety and Efficacy With NOVOCART® Disc Plus (ADCT) for the Treatment of Degenerative Disc Disease in Lumbar Spine (NCT01640457) | Tetec AG | 2012-08-01 |
| Everolimus in Combination With DHAP in Patients With Relapsed or Refractory Hodgkin Lymphoma (NCT01453504) | University of Cologne | 2012-08-01 |
| Optimization of Desflurane in Elderly Patients (NCT01700907) | Sapporo Medical University | 2012-08-01 |
| A Study of Blood Levels of Nicotine Following an Electronic Cigarette (NCT02794220) | Simbec Research | 2012-08-01 |
| Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fasting Condition (NCT01741623) | IPCA Laboratories Ltd. | 2012-08-01 |
| Safety and Efficacy Study of a New Device for Making Neochordae in Mitral Valve Repair (NCT01811537) | Tehran University of Medical Sciences | 2012-08-01 |
| The eMESH 1 Feasibility Study (NCT01676376) | Kips Bay Medical, Inc. | 2012-08-01 |
| A Phase I Clinical Trial of an HPV Therapeutic Vaccine (NCT01653249) | University of Arkansas | 2012-08-01 |
| A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma (NCT01677390) | Seagen Inc. | 2012-08-01 |
| Photopill Treatment in Healthy Volunteers (NCT01702662) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2012-08-01 |
| Total Marrow Irradiation for Refractory Acute Leukemia (NCT00686556) | Masonic Cancer Center, University of Minnesota | 2012-08-01 |
| Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 Years (NCT01676402) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-08-01 |
| Boceprevir and Ucalm (St John&Apos;s Wort) (NCT01663922) | St Stephens Aids Trust | 2012-08-01 |
| Cilengitide Imaging Trial in Glioblastoma (NCT01558687) | Merck KGaA, Darmstadt, Germany | 2012-08-01 |
| Evaluating the Safety and Priming Response of an HIV Vaccine Regimen in Healthy, HIV-Uninfected Adults (NCT01799954) | HIV Vaccine Trials Network | 2012-08-01 |
| Assessment of the Manageability and Safety of ADBLOCK Adhesion Barrier System in Laparoscopic Gynaecological Surgery (NCT01745432) | Terumo Europe N.V. | 2012-08-01 |
| Bacterial Interference for Prevention of Catheter-Associated UTI: Geriatric Pilot Study (NCT00554996) | US Department of Veterans Affairs | 2012-08-01 |
| Study Comparing Magnetic Seizure Therapy (MST) to Electroconvulsive Therapy (ECT) for Depression in Older Adults (NCT01869374) | New York State Psychiatric Institute | 2012-08-01 |
| Sildenafil Trial in Children and Young Adults With CF (NCT01194232) | Children's Hospital Medical Center, Cincinnati | 2012-08-01 |
| A Study to Evaluate the Safety of ASP2408 After Subcutaneous Administration to Healthy Male Subjects (NCT02140125) | Astellas Pharma Inc | 2012-08-01 |
| Pravastatin for Prevention of Preeclampsia (NCT01717586) | The University of Texas Medical Branch, Galveston | 2012-08-01 |
| Northern Board Beet Breathlessness Trial (NCT01610024) | Northern Health and Social Care Trust | 2012-08-01 |
| Study in HCV-Infected Patients to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of JNJ-47910382 (NCT01651767) | Janssen R&D Ireland | 2012-08-01 |
| Evaluation of a Single Vaccination of One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) and a Single Dose Level of a 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) in Healthy Adults Aged 65 to <86 Years (NCT01643941) | Pfizer | 2012-08-01 |
| A Pilot Study of Xifaxan to Treat Patients With PSC (NCT01695174) | Mayo Clinic | 2012-08-01 |
| 2-Part Multiple Ascending Dose Study for Safety and Pharmacokinetics in Healthy and Elderly Subjects (NCT01673451) | Eisai Inc. | 2012-08-01 |
| Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects (NCT01702649) | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | 2012-08-01 |